In line with this view, immunohistochemical analysis of TWIST1 in human non-invasive breast cancers (ductal carcinomas in situ, DCIS) has revealed frequent overexpression of this EMT inducer within the bulk of the primary lesion, while the cancer cells maintain an epithelial phenotype (Figure S13). Here, TWIST1 is linked to ductal breast carcinoma in situ.